The Right Blend
We are building a different kind of biopharma company.
We are focusing on identifying and developing therapeutics through efficient
and ongoing collaboration with our partners, whether big pharmaceutical companies,
early-stage startups, or academia.
We have the right blend of scientific, medical, operational, and
company-building experience, along with a broad network of
contacts needed to identify, finance, develop and commercialize
programs that can dramatically transform patients’ lives.
We also know how to develop an organization that can balance
what is optimal for patients with the needs of providers, payors
and shareholders.
Why ACELYRIN
Search and Select
the Best
We leverage the global network of the co-founders and investors to identify the most promising assets using their cumulative development and commercial expertise.
OUR NETWORK
Global Network of Relationships
Through our global network of relationships across senior pharma and biotech management, academia, investors and bankers, the ACELYRIN Team identifies, acquires and accelerates the development of the most promising therapeutic programs that can transform patients’ lives.
OUR FOCUS
We conduct a licensing and acquisition search process that is both directed and opportunistic.
Our directed search will be in the field of immunology, where we have deep expertise and resources needed to create value.
Opportunistically, we are open to platforms, programs and products when compelling science or data exist, particularly for clinical stage assets.
